Skip Navigation

Europace 2001 3(3):195-200; doi:10.1053/eupc.2001.0167
© 2001 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, D. S. Y.
Right arrow Articles by Newman, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, D. S. Y.
Right arrow Articles by Newman, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


ABLATION

Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?

D. S. Y. Lee1, P. Dorian1, E. Downar2, M. Burns1, E. L. Yeo3, W. L. Gold3, M. Paquette1, W. Lau1 and D. M. Newman1

1St Michael's Hospital, Division of Cardiology University of Toronto ; 2Toronto General Hospital, Division of Cardiology University of Toronto Toronto, Canada; 3Toronto General Hospital, Divisions of Hematology and Internal Medicine University of Toronto Toronto, Canada

Abstract

AIMS: Thromboembolic complications have been reported after radiofrequency ablation but the low incidence of overt clinical events has been a limitation to the study of factors affecting thrombogenic risk. The aim of this study was to determine whether radiofrequency ablation has a procoagulant effect and to examine variables that affect thrombin generation.

METHODS AND RESULTS: Thirty-seven consecutive patients who underwent radiofrequency ablation were studied prospectively. Blood samples were assayed for thrombin-antithrombin III (TAT) and d-dimer (DD) at five different time points: (1) baseline; (2) after sheath insertion; (3) after electrophysiological study but before radiofrequency ablation; (4) at completion of the procedure; and (5) 24 h post-procedure.

TAT levels were within the normal range at baseline and increased significantly after sheath insertion from 2·1±1·2 µg l–1to 13·3±16·0 µg l–1(P< 0·01). Levels increased further to 24·0±19·9 µg l–1(P< 0·01) after electrophysiological study but did not increase after radiofrequency ablation. TAT normalized at 24 h. DD increased significantly from baseline values (230·2±176·8 ng ml–1) to 285·4±237·4 ng ml–1(P=0·019) after sheath insertion. There was a further significant increase after electrophysiological study to 423·4±324·3 ng ml–1(P< 0·01), and a slight but non-significant increase to 464·4±307·4 ng ml–1after radiofrequency ablation (P=0·159). DD remained elevated at 24 h. Procedure duration was the only variable that correlated with the relative increase in TAT and DD. The patients with the longest procedure durations had more catheters inserted, more radiofrequency applications and largely consisted of accessory bypass tract-mediated tachycardias. Heparin administration significantly blunted the relative increase in TAT after radiofrequency ablation (P=0·005).

CONCLUSION: Radiofrequency ablation procedures confer an increased risk of thrombosis. Catheterization and diagnostic study contribute largely to the thrombogenic stimulus. Thrombogenicity is increased in prolonged, complex procedures and is decreased in patients who have been administered heparin during the procedure.

Key Words: Radiofrequency ablation, thrombosis, heparin


Correspondence: Dr David Newman, 30 Bond St., Room 7-051Q, Toronto, Ontario, Canada, M5B 1W8. E-mail: newmand{at}smh.toronto.on.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
J. W. Schrickel, L. Lickfett, T. Lewalter, E. Mittman-Braun, S. Selbach, K. Strach, C. P. Nahle, J. O. Schwab, M. Linhart, R. Andrie, et al.
Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation
Europace, November 20, 2009; (2009) eup350v1.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. B. Rahmanian, J. G. Castillo, D. Mehta, D. H. Adams, and F. Filsoufi
Epicardial Pulmonary Vein Isolation: A Long-Term Histologic and Imaging Animal Study Comparing Cryothermy Versus Radiofrequency
Ann. Thorac. Surg., September 1, 2008; 86(3): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.